000 01615 a2200493 4500
005 20250515191540.0
264 0 _c20091113
008 200911s 0 0 eng d
022 _a1532-1827
024 7 _a10.1038/sj.bjc.6605346
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNovello, S
245 0 0 _aPhase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer.
_h[electronic resource]
260 _bBritish journal of cancer
_cNov 2009
300 _a1543-8 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyrroles
_xadministration & dosage
650 0 4 _aSunitinib
700 1 _aScagliotti, G V
700 1 _aRosell, R
700 1 _aSocinski, M A
700 1 _aBrahmer, J
700 1 _aAtkins, J
700 1 _aPallares, C
700 1 _aBurgess, R
700 1 _aTye, L
700 1 _aSelaru, P
700 1 _aWang, E
700 1 _aChao, R
700 1 _aGovindan, R
773 0 _tBritish journal of cancer
_gvol. 101
_gno. 9
_gp. 1543-8
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6605346
_zAvailable from publisher's website
999 _c19219848
_d19219848